U S PHYSICAL THERAPY INC /NV Debt Instrument, Face Amount
U S PHYSICAL THERAPY INC /NV (USPH) had Debt Instrument, Face Amount of $222.50 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-07
- 2026-06-30: Debt Instrument, Face Amount $222.50M.
- 2026-03-31: Debt Instrument, Face Amount $205.35M.
- 2025-12-31: Debt Instrument, Face Amount $163.08M.
- 2025-09-30: Debt Instrument, Face Amount $160.99M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2026-06-30 | $222.50M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $205.35M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $163.08M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $160.99M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $160.91M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $167.44M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $154.58M 10-K · filed 2026-02-27 |
| 2024-09-30 | $143.68M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $146.63M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $147.32M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $148.15M 10-K · filed 2025-03-03 |
| 2023-09-30 | $150.64M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $152.64M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $192.17M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $185.56M 10-K · filed 2024-02-29 |
| 2022-09-30 | $156.12M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $155.70M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $118.42M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |